NASDAQ:ACLX

Arcellx stock sticks near $115 after Gilead bid — what could move ACLX next

Arcellx finished Tuesday at $113.75, flat on the day, and then slipped a nickel to $113.70 after the bell—still parked just shy of Gilead’s $115 per share bid. Since the buyout was announced, the stock has surged roughly 77% from its Feb. 20 close.

25 February 2026

NASDAQ:ACLX·NASDAQ:GILD·Stock Market

Arcellx stock steadies near $115 after Gilead’s $7.8 billion takeover bid — what traders watch next

Arcellx edged up 0.1% to $113.86 in late-morning trading Tuesday, still trading a touch below the cash offer from Gilead Sciences.

24 February 2026

NASDAQ:ACLX·NASDAQ:GILD·Stock Market

Arcellx stock jumps 78% on Gilead’s $7.8 billion buyout — deal terms, risks and next catalyst

Arcellx shares were up $49.73, or about 77.6%, at $113.84 in midday New York trade on Monday after Gilead Sciences moved to buy the cancer therapy developer. Gilead slipped 0.6% to $150.42.

23 February 2026

NASDAQ:ACLX·NASDAQ:GILD·Stock Market

Arcellx stock surges toward $115 buyout price after Gilead deal sets new ceiling

Shares of Arcellx surged roughly 78% to $113.92 Monday morning, following news that Gilead Sciences will acquire the cancer therapy maker—pushing the stock close to the buyout price. The takeover puts Arcellx’s valuation as high as $7.8 billion, factoring in a contingent sales-related bonus.

23 February 2026

NASDAQ:ACLX·NASDAQ:GILD·NASDAQ:LEGN·NYSE:JNJ·Stock Market

Arcellx (ACLX) Stock Surges on Anito-cel Breakthrough Data as Analysts Boost Price Targets – December 9, 2025

Arcellx, Inc. has jumped back onto Wall Street’s radar after releasing highly positive Phase 2 data for its multiple myeloma cell therapy anitocabtagene autoleucel at the American Society of Hematology 2025 meeting. The new data have driven a sharp move in the stock, a flurry of analyst updates, and renewed debate about valuation ahead of a planned 2026 commercial launch.

9 December 2025

Biotechnology·NASDAQ:ACLX·Stock Market

NASDAQ:ACLX 9 December 2025 - 25 February 2026

Arcellx stock sticks near $115 after Gilead bid — what could move ACLX next

Arcellx stock steadies near $115 after Gilead’s $7.8 billion takeover bid — what traders watch next

Arcellx stock jumps 78% on Gilead’s $7.8 billion buyout — deal terms, risks and next catalyst

Arcellx stock surges toward $115 buyout price after Gilead deal sets new ceiling

Arcellx (ACLX) Stock Surges on Anito-cel Breakthrough Data as Analysts Boost Price Targets – December 9, 2025

TechStock² Updates

Westwater Resources (NYSEAMERICAN:WWR) shares surge 88% with estimated market capitalization increase exceeding U.S. graphite loan amount

The Trade Desk (NASDAQ:TTD) falls 22% after outlook signals ad spending adjustment

SpaceX (NASDAQ:SPCX) Shares Jump 16% as Investor Attention Moves From Lockups to AI-Driven Gains

Palantir Technologies (NASDAQ:PLTR) Ends 40% Weekly Rally as Backlog Expansion Coincides With 51x Sales Guidance on Valuation

Social Security COLA for 2027 May Top Trustees’ Forecast, Adding $63 Billion

Top Stock Picks

Constellation Energy

AerCap

Walt Disney

AIG

Cheniere Energy

Live updates

Investment Disclaimer